TrialCancer chemotherapy and pharmacology2013

Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study.

Eric Van Den Neste et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.